CN114394949A - Biphenylamine derivative and organic electroluminescent device thereof - Google Patents

Biphenylamine derivative and organic electroluminescent device thereof Download PDF

Info

Publication number
CN114394949A
CN114394949A CN202210090065.4A CN202210090065A CN114394949A CN 114394949 A CN114394949 A CN 114394949A CN 202210090065 A CN202210090065 A CN 202210090065A CN 114394949 A CN114394949 A CN 114394949A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
group
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210090065.4A
Other languages
Chinese (zh)
Other versions
CN114394949B (en
Inventor
郭建华
李梦茹
孙月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changchun Hyperions Technology Co Ltd
Original Assignee
Changchun Hyperions Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changchun Hyperions Technology Co Ltd filed Critical Changchun Hyperions Technology Co Ltd
Priority to CN202210090065.4A priority Critical patent/CN114394949B/en
Publication of CN114394949A publication Critical patent/CN114394949A/en
Application granted granted Critical
Publication of CN114394949B publication Critical patent/CN114394949B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/624Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing six or more rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention provides a biphenyl derivative and an organic electroluminescent device thereof, belonging to the technical field of organic electroluminescence. The benzidine derivative provided by the invention introduces five-membered alicyclic ring and furan/thiophene on the basis of benzidine, so that the molecule movement of the benzidine derivative is reduced in space, and the molecular crystallization trend is effectively inhibited, thus the compound has good film forming property and thermal stability, and meanwhile, the benzidine derivative has higher HOMO energy level and good hole mobility, and when the benzidine derivative is used as a hole transport layer/light-emitting auxiliary layer material, the hole injection and transport balance in a device can be improved, the light-emitting efficiency of the device is greatly improved, and the service life of the device is greatly prolonged. The benzidine derivative and the organic electroluminescent device thereof have good application effect and industrialization prospect.

Description

Biphenylamine derivative and organic electroluminescent device thereof
Technical Field
The invention relates to the technical field of organic electroluminescence, in particular to a benzidine derivative and an organic electroluminescent device thereof.
Background
Organic Light-emitting Devices (OLEDs) refer to Devices in which holes injected from an anode and electrons injected from a cathode are transported and recombined in an Organic layer to form excitons, which in turn emit Light. Alq of sandwich structure was published for the first time by Tang et al3Since the electroluminescence of green devices, OLEDs are highly focused and widely researched by their advantages of being light, thin, foldable, flexible to display, surface-emitting, and low in power consumption.
OLEDs generally have a structure of an anode, a cathode, and an organic layer, and the organic layer is generally formed as a multi-layer structure composed of various materials, for example, a hole transport region, an electron transport region, a light emitting layer, a capping layer, and the like, in order to improve efficiency and lifespan of an organic electroluminescent device. The light-emitting mechanism is as follows: under the drive of an external voltage, electrons enter the electron transmission area layer from the cathode, holes enter the hole transmission area layer from the anode, the electrons and the holes are combined in the light emitting layer to generate excitons, and the excitons are radiatively transited back to the ground state and emit light. The lighting process can be summarized as the following four steps: (1) injecting carriers; (2) the transmission of carriers in the organic layer; (3) the positive and negative carriers are combined to form excitons; (4) the exciton radiates transition luminescence.
The hole transport region, which has a main function of injecting and transporting holes, may be classified into a hole injection layer, a hole transport layer, a light emission auxiliary layer, an electron blocking layer, and the like. The hole transport material has the main effects of improving the injection and transmission balance of holes in the device, the hole transport material with excellent performance can reduce the energy barrier in the hole injection process, the hole injection efficiency is improved, meanwhile, the hole transport rate in the device can be improved through good hole mobility, the hole transport rate and the electron transport rate are balanced, and holes and electrons are effectively compounded in the light-emitting layer to form excitons. Therefore, the development of a class of hole transport materials with excellent performance is crucial to the development of OLEDs.
Disclosure of Invention
In order to improve the hole injection efficiency and the transmission efficiency in the device and balance the hole transmission rate and the electron transmission rate in the device, the invention provides a biphenyl derivative and an organic electroluminescent device thereof. The benzidine derivative provided by the invention has good hole mobility and thermal stability, and can be used as a hole transport material to be applied to an organic electroluminescent device, so that the luminous efficiency of the device can be effectively improved, and the service life of the device can be effectively prolonged.
The invention provides a benzidine derivative, which has the following structure,
Figure BDA0003488815610000011
wherein, Ar is1Selected from the group consisting of the structures represented by chemical formula 2,
Figure BDA0003488815610000012
the ring A is selected from any one of the structures shown below,
Figure BDA0003488815610000021
ar is2~Ar4At least one of them is selected from the group consisting of the structure shown in chemical formula 3, and the others are the same or different and are selected from the group consisting of chemical formula 2, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C1-C25 heterocycloalkyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C25 alicyclic ring and C2-C30 heteroaromatic groupFused ring group of ring, -any one of N (Ra) (Rb);
the Ra and the Rb are the same or different and are selected from any one of substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 alicyclic ring, fused ring group of C6-C30 aromatic ring and substituted or unsubstituted C2-C30 heteroaryl;
Figure BDA0003488815610000022
x is selected from O or S;
the R is1、R2、R3Any one of the same or different selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocyclic alkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 alicyclic ring, C6-C30 aromatic ring fused ring group, and substituted or unsubstituted C2-C30 heteroaryl;
n is1Selected from 0,1, 2,3 or 4; when n is1Greater than 1, two or more R1Are the same or different from each other, or adjacent R1May form a substituted or unsubstituted ring;
n is2Selected from 0,1, 2,3, 4,5, 6 or 7; when n is2Greater than 1, two or more R2Are the same or different from each other;
n is4Selected from 0,1, 2,3, 4,5, 6 or 7; when n is4Greater than 1, two or more R3Are the same or different from each other, or adjacent R3May form a substituted or unsubstituted ring;
said L1~L4The same or different are selected from single bond, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C6-C30 arylene group, substituted or unsubstituted C3-C30 alicyclic group and CAny one of a fused cyclic group of an aromatic ring of 6 to C30, a substituted or unsubstituted heteroarylene group of C2 to C30;
n is3Selected from 1,2, 3 or 4; when n3 is greater than 1, two or more
Figure BDA0003488815610000023
The same or different from each other.
The invention also provides an organic electroluminescent device which comprises an anode, a cathode and an organic layer between and outside the anode and the cathode, wherein the organic layer comprises a hole transport region, a light-emitting layer and an electron transport region, and the hole transport region contains one or more of the benzidine derivatives.
The invention has the beneficial effects that:
the benzidine derivative provided by the invention changes the molecular structure by introducing five-membered alicyclic ring and furan/thiophene modification into benzidine, forms a compound with large steric hindrance, increases the number of molecular conformational isomers, reduces the movement of molecules in space, further reduces the aggregation force between molecules, and effectively inhibits the molecular crystallization trend, thereby improving the film forming property and the thermal stability of the compound; meanwhile, benzidine + five-membered alicyclic ring + furan/thiophene enables electrophilic N atoms in the structure to attract electrons on aromatic rings through an induction effect, meanwhile, due to P-pi conjugation effect, unshared electrons on the N atom are supplied to the aromatic ring to enrich the electrons, the conjugation effect is larger than the induction effect, on the other hand, the special conjugation system of the derivative expands the electron delocalization range, so that the mobility of electrons in molecules is enhanced, the HOMO energy level of the benzidine derivative is effectively improved, the electron energy is reduced, the hole mobility of the material is greatly improved, when the benzidine derivative is used as a hole transport material to be evaporated into a device, the injection and the transport of holes in the device can be improved, the hole transmission rate and the electron transmission rate of the device are balanced, and holes and electrons are effectively compounded in the light-emitting layer to form excitons, so that the light-emitting efficiency of the device is greatly improved.
Detailed Description
The following will clearly and completely describe the technical solutions of the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the scope of protection of the present invention.
In the context of the present specification,
Figure BDA0003488815610000031
means a moiety attached to another substituent.
In the present specification, "-" means a moiety linked to another substituent.
In the present specification, when the position of a substituent on an aromatic ring is not fixed, it means that it can be attached to any of the corresponding optional positions of the aromatic ring. For example,
Figure BDA0003488815610000032
can represent
Figure BDA0003488815610000033
And so on.
The alkyl group in the present invention refers to a monovalent group formed by dropping one hydrogen atom from an alkane molecule, and may be a straight-chain alkyl group, a branched-chain alkyl group, preferably having 1 to 25 carbon atoms, preferably 1 to 12 carbon atoms, more preferably 1 to 10 carbon atoms, and particularly preferably 1 to 6 carbon atoms, and examples may include a methyl group, an ethyl group, a propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isopentyl group, a hexyl group, and the like, but are not limited thereto.
The alicyclic group in the present invention means a monovalent group formed by removing one hydrogen atom from an alicyclic hydrocarbon molecule, and may be a cycloalkyl group, a cycloalkenyl group, etc., preferably having 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, adamantyl, norbornyl, cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, etc.
The cycloalkyl group in the present invention means a monovalent group formed by subtracting one hydrogen atom from a cycloalkane molecule, and preferably has 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, and preferably 3 to 7 carbon atoms, and examples thereof may include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, adamantyl, norbornyl, and the like, but are not limited thereto.
The cycloalkenyl group in the present invention means a monovalent group formed by dropping one hydrogen atom from a cycloolefin molecule, and preferably has 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, and preferably 3 to 7 carbon atoms, and examples may include cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl and the like, but are not limited thereto.
The heterocycloalkyl group in the invention is a univalent group formed by subtracting one hydrogen atom from a heterocycloalkyl molecule, and the heteroatom can be one or more of N, O, S, Si and P. Preferably having 1 to 25 carbon atoms, more preferably 2 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include azetidinyl, tetrahydropyrrolyl, piperidinyl and the like, but are not limited thereto.
The aryl group in the present invention refers to a monovalent group obtained by removing one hydrogen atom from an aromatic core carbon of an aromatic hydrocarbon molecule, and may be a monocyclic aryl group, a polycyclic aryl group or a condensed ring aryl group, and preferably has 6 to 30 carbon atoms, preferably 6 to 18 carbon atoms, more preferably 6 to 14 carbon atoms, and most preferably 6 to 12 carbon atoms, and examples may include a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, an anthryl group, a phenanthryl group, a pyrenyl group, a triphenylene group, a perylene group, and the like, but are not limited thereto.
The fused cyclic group of the alicyclic ring and the aromatic ring in the invention refers to a general name of a monovalent group left by removing one hydrogen atom after the alicyclic ring and the aromatic ring are fused together. Preferably having 7 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, most preferably 7 to 12 carbon atoms, and examples may include benzocyclopropyl, benzocyclobutyl, benzocyclopentyl, benzocyclohexyl, benzocycloheptyl, benzocyclopentenyl, benzocycloheptenyl, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, and the like, but are not limited thereto.
The heteroaryl group in the present invention is a general term for a monovalent group obtained by removing a hydrogen atom from a nuclear atom of an aromatic heterocyclic ring composed of carbon and a hetero atom. The hetero atom may be one or more of N, O, S, Si, P, may be a monocyclic heteroaryl group or a fused heteroaryl group, preferably having 2 to 30 carbon atoms, preferably 2 to 20 carbon atoms, more preferably 2 to 16 carbon atoms, particularly preferably 3 to 12 carbon atoms, most preferably 3 to 8 carbon atoms, and examples may include pyrrolyl, pyridyl, pyrimidinyl, triazinyl, thienyl, furyl, indolyl, quinolyl, isoquinolyl, oxazolyl, thiazolyl, imidazolyl, benzothienyl, benzofuryl, benzoxazolyl, benzothiazolyl, benzimidazolyl, pyridooxazolyl, pyridothiazolyl, pyridoimidazolyl, pyrimidoxazolyl, pyrimidozolyl, pyrimido thiazolyl, pyrimido imidazolyl, dibenzofuryl, dibenzothienyl, carbazolyl, phenazinyl, quinoxalinyl, quinazolinyl, quinoxalyl, Quinolinothiazolyl, quinolinoimidazolyl, purinyl, 2-purinyl, N-imidazolyl, and the like, but is not limited thereto.
The fused cyclic group of the alicyclic ring and the heteroaromatic ring in the invention is a general term for removing one hydrogen atom after the alicyclic ring and the heteroaromatic ring are fused together to leave a monovalent group. Preferably having 5 to 30 carbon atoms, more preferably 5 to 18 carbon atoms, most preferably 5 to 12 carbon atoms, and examples may include pyridocyclopropyl, pyridocyclobutyl, pyridocyclopentyl, pyridocyclohexyl, pyridocycloheptyl, pyrimidocyclopropyl, pyrimidocyclobutyl, pyrimidocyclopentyl, pyrimidocyclohexyl, pyrimidocycloheptyl, dibenzofurocyclopropyl, dibenzofurocyclobutyl, dibenzofurocyclopentyl, dibenzofurocyclohexyl, dibenzofurocycloheptyl, dibenzothienocyclopropyl, dibenzothienocyclobutyl, dibenzothienocyclopentyl, dibenzothienocyclohexyl, dibenzothienocycloheptyl, carbazolocyclopropyl, carbazolocyclobutyl, carbazolocyclopentyl, carbazolocyclohexyl, carbazolocycloheptyl, and the like, but are not limited thereto.
The arylene group in the present invention refers to a general term of divalent groups remaining after two hydrogen atoms are removed from an aromatic nucleus of an aromatic hydrocarbon molecule, and may be monocyclic arylene group, polycyclic arylene group or condensed ring arylene group, preferably having 6 to 30 carbon atoms, preferably 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 18 carbon atoms, and most preferably 6 to 12 carbon atoms, and examples may include phenylene, biphenylene, terphenylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene, triphenylene, peryleneene, and the like, but are not limited thereto.
The heteroarylene group according to the present invention means a general term in which two hydrogen atoms are removed from the core carbon of an aromatic heterocyclic ring composed of carbon and hetero atoms, which may be one or more of N, O, S, Si, P, a monocyclic heteroarylene group or a condensed-ring heteroarylene group, preferably having 2 to 30 carbon atoms, preferably 2 to 20 carbon atoms, more preferably 2 to 16 carbon atoms, particularly preferably 3 to 12 carbon atoms, most preferably 3 to 8 carbon atoms, and examples may include a pyrrolylene group, a pyridylene group, a pyrimidylene group, a triazinylene group, a thienylene group, a furylene group, an indolyl group, a quinolylene group, an isoquinolylene group, an oxazolylene group, a thiazolyl group, a furylene group, a benzothiophenylene group, a benzofuranylene group, a benzoxazylene group, a benzothiazylene group, a benzimidazolylene group, a pyridazolylene group, a, Pyridinylimidazolylides, pyrimidinyleneoxazolyls, pyrimidinylenethiazolyls, pyrimidinyleneimidazolyls, dibenzofuranylenes, dibenzothiophenylenes, carbazolylenes, phenazinyls, quinoxalylenes, quinazolinylenes, quinolinyleneoxazolyls, quinolinylenethiazolyls, quinolinyleneimidazolyls, purinylenes, and the like, but are not limited thereto.
The alicyclic group in the present invention means a divalent group in which two hydrogen atoms are omitted from an alicyclic hydrocarbon molecule, and may be a cycloalkylene group, a cycloalkenylene group, or the like, preferably having 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include, but are not limited to, a cyclopropylene group, a cyclobutylene group, a cyclopentylene group, a cyclohexylene group, a cycloheptylene group, an adamantylene group, a norbornylene group, a cyclopropenylene group, a cyclobutenyl group, a cyclopentenylene group, a cyclohexenylene group, a cycloheptenylene group, or the like.
The term "fused ring group" of an alicyclic ring and an aromatic ring as used herein refers to a general term in which an alicyclic ring and an aromatic ring are fused together and then two hydrogen atoms are removed to leave a divalent group. Preferably having 7 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, most preferably 7 to 12 carbon atoms, and examples may include benzocyclobutene, benzocyclopentylene, benzocyclohexylene, benzocycloheptyl, benzocyclopentylene, benzocyclohexylene, benzocycloheptylene, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, and the like, but are not limited thereto.
The "substitution" as referred to herein means that a hydrogen atom in a compound group is replaced with another atom or group, and the position of substitution is not limited.
The "substituted or unsubstituted" as referred to herein means not substituted or substituted with one or more substituents selected from the group consisting of: deuterium, a halogen atom, an amino group, a cyano group, a nitro group, an alkyl group of C1 to C25, a cycloalkyl group of C3 to C25, an aryl group of C6 to C30, a heteroaryl group of C2 to C30, an arylamine group of C6 to C30, an aryloxy group of C6 to C30, preferably deuterium, a halogen atom, a cyano group, an alkyl group of C1 to C12, an aryl group of C6 to C25, a heteroaryl group of C2 to C25, and specific examples thereof may include deuterium, fluorine, chlorine, bromine, iodine, a cyano group, methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, benzocyclobutenyl, benzocyclopentyl, benzocyclocyclohexyl, benzocyclopentyl, benzocyclohexyl, benzocyclopentenyl, benzocyclobutenyl, phenyltritolyl, tolyl, mesityl, biphenylyl, naphthyl, anthryl, phenanthrenyl, triphenylenyl, phenanthrenyl, pyrenyl, and the like,
Figure BDA0003488815610000051
A phenyl group, a perylene group, a fluoranthenyl group, a 9, 9-dimethylfluorenyl group, a 9, 9-diphenylfluorenyl group, a 9-methyl-9-phenylfluorenyl group, a carbazolyl group, a 9-phenylcarbazolyl group, a spirobifluorenyl group, a carbazoloindolyl group, a pyrrolyl group, a furyl group, a thienyl group, an indolyl group, a benzofuryl group, a benzothienyl group, a dibenzofuryl group, a dibenzothienyl group, a pyridyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, an oxazolyl group, a thiazolyl group, an imidazolyl group, a benzoxazolyl group, a benzothiazolyl group, a benzotriazolyl group, a benzimidazolyl group, a pyridooxazolyl group, a pyridothiazolyl group, a pyridoimidazolyl group, a pyrimido oxazolyl group, a pyrimido imidazolyl group, a quinolyl group, an isoquinolyl group, a quinolonooxazolyl group, a quinolothiazolyl group, a phenothiazinyl group, a phenoxazinyl group, Acridinyl, and the like, but are not limited thereto. Or when the substituents are two or more, adjacent substituents may be bonded to form a ring; when the substituents are two or more, the substituents may be the same as or different from each other.
The linking to form a substituted or unsubstituted ring according to the present invention means that the two groups are linked to each other by a chemical bond and optionally aromatized. As exemplified below:
Figure BDA0003488815610000061
in the present invention, the ring formed by the connection may be a five-membered ring or a six-membered ring or a fused ring, and examples may include benzene, pyridine, pyrimidine, naphthalene, cyclopentene, cyclopentane, cyclohexane, cyclohexano, quinoline, isoquinoline, dibenzothiophene, phenanthrene or pyrene, but are not limited thereto.
The invention provides a benzidine derivative, which has the following structure,
Figure BDA0003488815610000062
wherein, Ar is1Selected from the group consisting of the structures represented by chemical formula 2,
Figure BDA0003488815610000063
the ring A is selected from any one of the structures shown below,
Figure BDA0003488815610000064
ar is2~Ar4At least one of them is selected from the group consisting of the structure of chemical formula 3, and the others are the same or different and selected from any one of chemical formula 2, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C1-C25 heterocycloalkyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C25 alicyclic ring and C2-C30 fused ring group, — N Ra and (Rb);
the Ra and the Rb are the same or different and are selected from any one of substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 alicyclic ring, fused ring group of C6-C30 aromatic ring and substituted or unsubstituted C2-C30 heteroaryl;
Figure BDA0003488815610000065
x is selected from O or S;
the R is1、R2、R3The same or different hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocyclic alkyl, substituted or unsubstituted C6-C30 aromatic hydrocarbonAny one of a group, a fused ring group of a substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring, and a substituted or unsubstituted C2-C30 heteroaryl;
n is1Selected from 0,1, 2,3 or 4; when n is1Greater than 1, two or more R1Are the same or different from each other, or adjacent R1May form a substituted or unsubstituted ring;
n is2Selected from 0,1, 2,3, 4,5, 6 or 7; when n is2Greater than 1, two or more R2Are the same or different from each other;
n is4Selected from 0,1, 2,3, 4,5, 6 or 7; when n is4Greater than 1, two or more R3Are the same or different from each other, or adjacent R3May form a substituted or unsubstituted ring;
said L1~L4Any one of the same or different single bonds, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C6-C30 arylene group, substituted or unsubstituted C3-C30 alicyclic group, substituted or unsubstituted C6-C30 aromatic ring fused cyclic group and substituted or unsubstituted C2-C30 heteroarylene group;
n is3Selected from 1,2, 3 or 4; when n3 is greater than 1, two or more
Figure BDA0003488815610000071
The same or different from each other.
Preferably, the benzidine derivative is selected from any one of chemical formula 1-1 to chemical formula 1-8,
Figure BDA0003488815610000072
the R is1The same or different is selected from the group consisting of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted t-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted methyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted isopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted isopropyl, and substituted or unsubstituted tert-butyl,Any one of substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthryl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, and substituted or unsubstituted carbazolyl;
n is1Selected from 0,1, 2,3 or 4; when n is1Greater than 1, two or more R1Are the same or different from each other, or adjacent R1May form a substituted or unsubstituted ring therebetween.
Preferably, Ar is2~Ar4At least one selected from the group consisting of the structures represented by chemical formula 3, means Ar2Selected from the structures shown in chemical formula 3, or Ar3Selected from the structures shown in chemical formula 3, or Ar4Selected from the structures shown in chemical formula 3, or Ar2And Ar3Selected from the structures shown in chemical formula 3, or Ar2And Ar4Selected from the structures shown in chemical formula 3, or Ar3And Ar4Selected from the structures shown in chemical formula 3, or Ar2、Ar3And Ar4Selected from the structures shown in chemical formula 3.
Preferably, the chemical formula 3 is selected from any one of the structures shown below,
Figure BDA0003488815610000081
X0any one selected from O, S, C (Rc) (Rd) and N (Re);
the R is3Rc, Rd are the same or different and are selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropylAny one of a group, a substituted or unsubstituted tert-butyl group, a substituted or unsubstituted cyclopropyl group, a substituted or unsubstituted cyclobutyl group, a substituted or unsubstituted cyclopentyl group, a substituted or unsubstituted cyclohexyl group, a substituted or unsubstituted cyclopentenyl group, a substituted or unsubstituted cyclohexenyl group, a substituted or unsubstituted adamantyl group, a substituted or unsubstituted norbornyl group, a substituted or unsubstituted piperidinyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted triphenylenyl group, a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted fluorenyl group, and a substituted or unsubstituted carbazolyl group;
the Re is selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, Any one of substituted or unsubstituted carbazolyl groups.
Preferably, the chemical formula 3 is selected from any one of the structures shown below,
Figure BDA0003488815610000091
preferably, the chemical formula 2 is selected from any one of the structures shown below,
Figure BDA0003488815610000092
preferably, Ar is2~Ar4At least one of them is selected from the group consisting of the structures represented by chemical formula 3, and the remaining same or different are selected from any one of chemical formula 2, a substituted or unsubstituted methyl group, a substituted or unsubstituted ethyl group, a substituted or unsubstituted n-propyl group, a substituted or unsubstituted isopropyl group, a substituted or unsubstituted isobutyl group, a substituted or unsubstituted t-butyl group, a substituted or unsubstituted cyclopropyl group, a substituted or unsubstituted cyclobutyl group, a substituted or unsubstituted cyclopentyl group, a substituted or unsubstituted cyclohexyl group, a substituted or unsubstituted cyclopentenyl group, a substituted or unsubstituted cyclohexenyl group, a substituted or unsubstituted adamantyl group, a substituted or unsubstituted norbornyl group, a substituted or unsubstituted piperidyl group, or the structures represented below,
Figure BDA0003488815610000101
said Y is1、Y2The same or different is selected from O, S, C (Rf) (Rg) and N (Rh);
the R is4、R5、R6、R7Rf and Rg are the same or different and are selected from the group consisting of hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted t-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornanyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, and substituted or unsubstituted methylOr any one of unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothienyl, substituted or unsubstituted fluorenyl and substituted or unsubstituted carbazolyl;
the Rh is selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, Any one of substituted or unsubstituted carbazolyl groups;
m is1Selected from 0,1, 2,3, 4 or 5; m is2Selected from 0,1, 2,3 or 4; m is3Selected from 0,1, 2,3, 4,5, 6 or 7; m is4Selected from 0,1, 2,3, 4,5, 6,7, 8 or 9; m is5Selected from 0,1, 2,3, 4,5, 6,7 or 8; when m is1、m2、m3、m4、m5Greater than 1, two or more R4Are the same or different from each other, two or more R5Are the same or different from each other, or adjacent R4May form a substituted or unsubstituted ring, adjacent R5May form a substituted or unsubstituted ring;
said L0Is selected from any one of single bond, substituted or unsubstituted arylene of C6-C18 and substituted or unsubstituted heteroarylene of C2-C18.
Preferably, Ar is2~Ar4At least one of them is selected from the structures shown in chemical formula 3, and the others are the same or different and are selected from the structures shown in chemical formula 2Substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted n-propyl, substituted or unsubstituted isopropyl, substituted or unsubstituted isobutyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, or any of the structures shown below,
Figure BDA0003488815610000111
Figure BDA0003488815610000121
Figure BDA0003488815610000131
Figure BDA0003488815610000141
preferably, said L1~L3The same or different is selected from a single bond or any one of the structures shown below,
Figure BDA0003488815610000142
wherein, R is8、R9Any one of the same or different hydrogen, deuterium, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C6-C18 aryl and substituted or unsubstituted C2-C12 heteroaryl;
k is1Identical or different from 0,1, 2,3 or 4, k2Identical or different from 0,1, 2,3, 4,5 or 6, k3The same or different is selected from 0 and 12,3, 4,5, 6,7 or 8, k4The same or different is selected from 0,1, 2 or 3; when k is1、k2、k3、k4Greater than 1, two or more R9R being identical or different from each other, or adjacent to each other9May form a substituted or unsubstituted ring therebetween.
Preferably, said L1~L3The same or different is selected from a single bond or any one of the structures shown below,
Figure BDA0003488815610000143
Figure BDA0003488815610000151
the R is8The same or different ones are selected from any one of hydrogen, methyl, ethyl, isopropyl, tert-butyl, phenyl, tolyl, pentadeuterated phenyl, naphthyl and deuterated naphthyl.
Preferably, the benzidine derivative has any one of the structures shown below,
Figure BDA0003488815610000152
Figure BDA0003488815610000161
Figure BDA0003488815610000171
Figure BDA0003488815610000181
Figure BDA0003488815610000191
Figure BDA0003488815610000201
Figure BDA0003488815610000211
Figure BDA0003488815610000221
Figure BDA0003488815610000231
Figure BDA0003488815610000241
Figure BDA0003488815610000251
Figure BDA0003488815610000261
Figure BDA0003488815610000271
Figure BDA0003488815610000281
the invention also provides a preparation method of the biphenyl derivative,
Figure BDA0003488815610000282
xa, which may be identical or different, are selected from I, Br, Cl;
Ar1-Ar4、L1-L4、R1、n1、n3the definitions are the same as above;
the reaction type of the benzidine derivative is Buchwald reaction.
The present invention may be bonded to the above-mentioned substituents through a method known in the art, and the kind and position of the substituents or the number of the substituents may be changed according to the technique known in the art.
The invention provides an organic electroluminescent device which comprises an anode, a cathode and an organic layer between and outside the anode and the cathode, wherein the organic layer comprises a hole transport region, a luminescent layer and an electron transport region, and the hole transport region contains one or more than one of the benzidine derivatives.
The hole transport region of the present invention includes at least one of a hole injection layer, a hole transport layer, and a light emission auxiliary layer.
Preferably, the hole transport region includes a hole injection layer containing one or more of the benzidine derivatives of the present invention.
Preferably, the hole transport region comprises a hole transport layer containing one or more of the benzidine derivatives of the present invention.
Preferably, the hole transport region includes a light emission auxiliary layer containing one or more of the benzidine derivatives of the present invention.
The electron transport region of the present invention includes at least one of an electron injection layer, an electron transport layer, and a hole blocking layer.
The organic layer of the present invention may further include a capping layer, an encapsulation layer, and the like. However, the structure of the organic electroluminescent device of the present invention is not limited to the above structure, and if necessary, the organic layers may be omitted or simultaneously have a plurality of organic layers, and the organic layers having the same function may be formed in a stacked structure of two or more layers.
The light-emitting layer of the present invention may include a host material, a dopant material, and the like, and may be formed of a single-layer structure or a multilayer structure in which layers above each other are stacked.
The organic electroluminescent device of the present invention preferably has the following structure:
substrate/anode/hole injection layer/hole transport layer/light emitting layer/electron transport layer/electron injection layer/cathode;
substrate/anode/hole injection layer/hole transport layer/light emitting layer/electron transport layer/electron injection layer/cathode/capping layer;
substrate/anode/hole injection layer/hole transport layer/light emitting layer/hole blocking layer/electron transport layer/electron injection layer/cathode;
substrate/anode/hole injection layer/hole transport layer/light emitting layer/hole blocking layer/electron transport layer/electron injection layer/cathode/capping layer;
substrate/anode/hole injection layer/hole transport layer/electron blocking layer/luminescent layer/hole blocking layer/electron transport layer/electron injection layer/cathode;
substrate/anode/hole injection layer/hole transport layer/electron blocking layer/luminescent layer/hole blocking layer/electron transport layer/electron injection layer/cathode/cover layer;
substrate/anode/hole injection layer/hole transport layer/light-emitting auxiliary layer/light-emitting layer/hole blocking layer/electron transport layer/electron injection layer/cathode;
substrate/anode/hole injection layer/hole transport layer/light-emitting auxiliary layer/light-emitting layer/hole blocking layer/electron transport layer/electron injection layer/cathode/cover layer;
however, the structure of the organic electroluminescent device is not limited thereto. The organic electroluminescent device can be selected and combined according to the parameter requirements of the device and the characteristics of materials, part of organic layers can be added or omitted, and the organic layers with the same function can be made into a laminated structure with more than two layers.
The organic electroluminescent device of the present invention is generally formed on a substrate. The substrate may be any substrate as long as it does not change when forming an electrode or an organic layer, for example, a substrate of glass, plastic, a polymer film, silicon, or the like.
In the organic electroluminescent device according to the present invention, it is preferable to use a high work function material capable of promoting hole injection into the organic layer as the anode material. Specific examples of the anode material usable in the present invention may include: metals such as vanadium, chromium, copper, zinc and gold, or alloys thereof; metal oxides such as zinc oxide, Indium Tin Oxide (ITO), Indium Zinc Oxide (IZO); combinations of metals and oxides, such as ITO-Ag-ITO; and conductive polymers such as poly (3-methylthiophene), polypyrrole, polyaniline, poly [3,4- (ethylene-1, 2-dioxy) thiophene ] (PEDT), and the like, but not limited thereto. Preferably, the anode material is selected from ITO, ITO-Ag-ITO and the like.
In the organic electroluminescent device according to the present invention, the hole injection material is preferably a material having a good hole accepting ability. Specific examples of the hole injection material that can be used in the present invention may include: metal oxides such as silver oxide, vanadium oxide, tungsten oxide, copper oxide, titanium oxide, phthalocyanine compound, benzidine compound, phenazine compound, and the like, for example, copper phthalocyanine (CuPc), titanyl phthalocyanine, N, N ' -diphenyl-N, N ' -di- [4- (N, N-diphenylamine) phenyl ] benzidine (NPNPNPNPB), N, N, N ', N ' -tetrakis (4-methoxyphenyl) benzidine (MeO-TPD), bisquinoxalino [2,3-a:2',3' -c ] phenazine (HATNA), 4' -tris [ 2-naphthylphenylamino ] triphenylamine (2T-NATA), 2,3,6,7,10, 11-hexacyano-1, 4,5,8,9, 12-hexaazatriphenylene (HAT-CN), 4,4' -tris (N, N-diphenylamino) triphenylamine (TDATA), and the like, but is not limited thereto. Preferably, the hole injection material of the present invention is selected from copper phthalocyanine (CuPc), 4',4 ″ -tris [ 2-naphthylphenylamino ] triphenylamine (2T-NATA), 4',4 ″ -tris (N, N-diphenylamino) triphenylamine (TDATA), and the like.
In the organic electroluminescent device of the present invention, the hole transport material is preferably a material having an excellent hole transport property and a HOMO level matched with a corresponding anode material. Specific examples of the hole transporting material usable in the present invention may include diphenylamines, triphenylamines, fluorenes and carbazoles, such as N, N ' -diphenyl-N, N ' - (1-naphthyl) -1,1' -biphenyl-4, 4' -diamine (NPB), N ' -di (naphthalen-1-yl) -N, N ' -di (phenyl) -2,2' -dimethylbenzidine (. alpha. -NPD), N ' -diphenyl-N, N ' -di (3-methylphenyl) -1,1' -biphenyl-4, 4' -diamine (TPD), 4- [1- [4- [ di (4-methylphenyl) amino ] phenyl ] cyclohexyl ] -N- (3-methylphenyl) -N- (4-methylphenyl) aniline (TAPC), the benzidine derivative according to the present invention, and the like, but is not limited thereto. Preferably, the hole transport material of the present invention is selected from one or more of the benzidine derivatives of the present invention.
In the organic electroluminescent device, the light-emitting auxiliary layer is preferably made of a material with good hole transport performance and electron blocking performance. Specific examples of the light-emitting auxiliary material usable in the present invention may include triarylamine derivatives, spirofluorene derivatives, furan derivatives, and the like, such as TPD, NPB, N4, N4-bis ([1,1 '-biphenyl ] -4-yl) -N4' -phenyl N4'- [1,1':4', 1' -terphenyl ] -4-yl- [1,1' -biphenyl ] -4,4' -diamine, N- ([1,1' -diphenyl ] -4-yl) -N- (9, 9-dimethyl-9H-furan-2-yl) -9,9' -spirobifluorene-2-amine, N-bis ([1,1' -biphenyl ] -4-yl) -3' - (dibenzo [ b, d ] furan-4-yl) - [1,1' -biphenyl ] -4-amine, benzidine derivatives described in the present invention, and the like, but are not limited thereto. Preferably, the material of the luminescence auxiliary layer according to the present invention is selected from one or more of the benzidine derivatives according to the present invention.
In the organic electroluminescent device of the present invention, the light-emitting layer material includes a light-emitting layer host material and a light-emitting layer dopant material, and the light-emitting layer host material may be selected from 4,4 '-bis (9-Carbazole) Biphenyl (CBP), 9, 10-bis (2-naphthyl) Anthracene (ADN), 4-bis (9-carbazolyl) biphenyl (CPB), 9' - (1, 3-phenyl) bis-9H-carbazole (mCP), 4',4 ″ -tris (carbazol-9-yl) triphenylamine (TCTA), 9, 10-bis (1-naphthyl) anthracene (α -ADN), N' -bis- (1-naphthyl) -N, N '-diphenyl- [1,1':4',1": 4', 1' -quaterphenyl.]-4,4' -diamino (4PNPB), 1,3, 5-tris (9-carbazolyl) benzene (TCP), and the like, but is not limited thereto. Preferably, the host material of the light emitting layer of the present invention is selected from 9, 10-bis (2-naphthyl) Anthracene (ADN), 9'- (1, 3-phenyl) bis-9H-carbazole (mCP), 4',4 ″ -tris (carbazole-9)-yl) triphenylamine (TCTA), 9, 10-bis (1-naphthyl) anthracene (α -AND), AND the like. The luminescent layer doping material can be selected from (6- (4- (diphenylamino (phenyl) -N, N-diphenylpyrene-1-amine) (DPAP-DPPA), 2,5,8, 11-tetra-tert-butylperylene (TBPe), 4' -bis [4- (diphenylamino) styryl]Biphenyl (BDAVBi), 4' -bis [4- (di-p-tolylamino) styryl]Biphenyl (DPAVBi), bis (2-hydroxyphenylpyridine) beryllium (Bepp2), bis (4, 6-difluorophenylpyridine-C2, N) picolinyliridium (FIrpic), tris (2-phenylpyridine) iridium (Ir (ppy)3) Bis (2-phenylpyridine) iridium acetylacetonate (Ir (ppy)2(acac)), 9, 10-bis [ N- (p-tolyl) anilino group]Anthracene (TPA), 4- (dicyanomethylene) -2-methyl-6- (4-dimethylaminostyryl) -4H-pyran (DCM), tris [ 1-phenylisoquinoline-C2, N]Iridium (III) (Ir (piq)3) Bis (1-phenylisoquinoline) (acetylacetonato) iridium (Ir (piq))2(acac)), etc., but is not limited thereto. Preferably, the light emitting layer guest of the present invention is selected from 4,4' -bis [4- (di-p-tolylamino) styryl]Biphenyl (DPAVBi), 2,5,8, 11-tetra-tert-butylperylene (TBPe), 9, 10-di [ N- (p-tolyl) anilino group]Anthracene (TPA), 4- (dicyanomethylene) -2-methyl-6- (4-dimethylaminostyryl) -4H-pyran (DCM), and the like.
The doping ratio of the host material for the light-emitting layer and the dopant material for the light-emitting layer is preferably different depending on the materials used, and is usually 0.01% to 20%, preferably 0.1% to 15%, more preferably 1% to 10%.
In the organic electroluminescent device according to the present invention, the hole blocking material has a strong hole blocking ability and suitable HOMO and LUMO levels, and specific examples of the hole blocking material that can be used in the present invention may include imidazoles, triazoles, phenanthroline derivatives, and the like, such as 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1, 2, 4-Triazole (TAZ), bis (2-methyl-8-hydroxyquinoline) (4-phenylphenol) aluminum (III) (BAlq), and the like, but are not limited thereto. Preferably, the hole blocking material according to the present invention is selected from 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), bis (2-methyl-8-hydroxyquinoline) (4-phenylphenol) aluminum (III) (BAlq), and the like.
In the organic electroluminescent device according to the present invention, the electron transport material is preferably a material having a strong electron withdrawing ability and low HOMO and LUMO levels, and specific examples of the electron transport material that can be used in the present invention may include imidazoles, triazoles, phenanthroline derivatives, quinolines, and the like, such as 2,9- (dimethyl) -4, 7-biphenyl-1, 10-phenanthroline (BCP), 1,3, 5-tris [ (3-pyridyl) -phenyl ] phenanthrene]Benzene (TmPyPB), 4' -bis (4, 6-diphenyl-1, 3, 5-triazinyl) biphenyl (BTB), 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1, 2, 4-Triazole (TAZ), 2- (naphthalen-2-yl) -4,7- (diphenyl) -1, 10-phenanthroline (HNBphen), 8-hydroxyquinoline-Lithium (LiQ), and the like, but are not limited thereto. Preferably, the electron transport material of the present invention is selected from 1,3, 5-tris (N-phenyl-2-benzimidazole) benzene (TPBi), tris (8-hydroxyquinoline) aluminum (III) (Alq)3) 8-hydroxyquinoline-lithium (Liq), bis (2-methyl-8-hydroxyquinoline) (4-phenylphenol) aluminum (III) (BALq) and the like, but are not limited thereto.
In the organic electroluminescent device according to the present invention, the electron injection material is preferably a material having a small difference in potential barrier with an adjacent organic transport material or host material, and has an effect of injecting electrons from the cathode. Examples of the electron injecting material that can be used in the present invention include: alkali metal salts (such as LiF, CsF), alkaline earth metal salts (such as MgF)2) Metal oxides (e.g. Al)2O3、MoO3) But is not limited thereto. Preferably, the electron injection material of the present invention is selected from lithium fluoride (LiF), 8-hydroxyquinoline-lithium (Liq), and the like.
In the organic electroluminescent device according to the present invention, a low work function material capable of promoting electron injection into the organic layer is preferably used as the cathode material. Specific examples of the cathode material that can be used in the present invention may include: metals such as aluminum, magnesium, silver, indium, tin, titanium, and the like, and alloys thereof; multilayer metallic materials, e.g. LiF/Al, Mg/Ag, Li/Al, LiO2/Al、BaF2Al, etc., but are not limited thereto. Preferably, the cathode according to the invention is selected from semi-transparent cathodes, such as Ag or Mg-Ag alloys or thin Al.
In the organic electroluminescent device according to the present invention, a material for improving optical coupling is preferably used as the material for the cover layer. Specific examples of the cover layer material that may be used in the present invention may include arylamine derivatives, carbazole derivatives, benzimidazole derivatives, triazole derivatives, lithium fluoride, and the like, but are not limited thereto. The coating layer may be formed on both the outer side of the anode and the outer side of the cathode, or may be disposed on the outer side of the anode or the outer side of the cathode, and preferably, the coating layer according to the present invention is disposed on the outer side of the cathode.
The present invention is not particularly limited to the thickness of each organic layer of the organic electroluminescent device, and may be any thickness commonly used in the art.
The organic electroluminescent device of the present invention may employ any one of vacuum evaporation, spin coating, vapor deposition, knife coating, laser thermal transfer, electrospray coating, slit coating, and dip coating, and in the present invention, vacuum evaporation is preferably employed.
The organic electroluminescent device can be widely applied to the fields of panel display, lighting sources, flexible OLEDs, electronic paper, organic solar cells, organic photoreceptors or organic thin film transistors, signs, signal lamps and the like.
The invention is explained in more detail by the following examples, without wishing to restrict the invention accordingly. Based on this description, one of ordinary skill in the art will be able to practice the invention and prepare other compounds and devices according to the invention within the full scope of the disclosure without undue inventive effort.
Preparation and characterization of the Compounds
Description of raw materials, reagents and characterization equipment:
the present invention is not particularly limited to the starting materials and sources of reagents used in the following examples, and they may be commercially available products or prepared by methods known to those skilled in the art.
The mass spectrum uses British Watts G2-Si quadrupole rod series time-of-flight high resolution mass spectrometer, chloroform is used as solvent;
the element analysis uses a Vario EL cube type organic element analyzer of Germany Elementar company, and the mass of a sample is 5-10 mg;
synthesis example 1: preparation of Compound 2
Figure BDA0003488815610000321
Preparation of intermediate c-2:
toluene (600mL), a-2(13.32g, 100.00mmol), b-2(24.71g, 100.00mmol), palladium acetate (0.34g, 1.5mmol), sodium tert-butoxide (19.22g, 200.00mmol) and tri-tert-butylphosphine (16mL of a 1.0M solution in toluene) were added to a reaction flask, dissolved by stirring, and the reaction was refluxed for 2 hours under nitrogen. After the temperature of the system is reduced to room temperature, the reaction solution is filtered by diatomite, filtrate is concentrated, recrystallization is carried out by methanol, the reaction solution is filtered, and filter cakes are collected to obtain c-2(23.35g, the yield is 78%), and the mass spectrum m/z is as follows: 299.1321 (theoretical value: 299.1310).
Preparation of intermediate f-2:
toluene (600mL), d-2(16.92g, 100.00mmol), e-2(23.31g, 100.00mmol), palladium acetate (0.34g, 1.5mmol), sodium tert-butoxide (19.22g, 200.00mmol) and tri-tert-butylphosphine (16mL of a 1.0M solution in toluene) were added to a reaction flask, dissolved by stirring, and the reaction was refluxed for 2 hours under nitrogen. After the temperature of the system was decreased to room temperature, the reaction solution was filtered through celite, the filtrate was concentrated, and recrystallized with toluene/methanol 4/1, the reaction solution was suction-filtered, the filter cake was washed with methanol, and the filter cake was collected to obtain f-2(27.32g, yield 85%), ms m/z: 321.1529 (theoretical value: 321.1517).
Preparation of intermediate h-2:
toluene (400mL), g-2(11.49g, 60.00mmol), c-2(17.96g, 60.00mmol), 1' -bis (diphenylphosphino) ferrocene palladium dichloride (0.66g, 0.90mmol) and potassium tert-butoxide (13.47g, 120mmol) were added to a reaction flask, dissolved with stirring and reacted under reflux for 3 hours under nitrogen. After the temperature of the system was reduced to room temperature, the reaction solution was filtered through celite, the filtrate was concentrated, and recrystallized with toluene/methanol 10/1, the reaction solution was suction-filtered, the filter cake was washed with methanol, and the filter cake was collected to obtain h-2(17.95g, yield 73%), mass m/z: 409.1221 (theoretical value: 409.1233).
Preparation of compound 2:
toluene (200mL), h-2(12.30g, 30.00mmol), f-2(10.61g, 33.00mmol), tris (dibenzylideneacetone) dipalladium (0.41g, 0.45mmol), potassium tert-butoxide (6.73g, 60.00mmol) and BINAP (1.87g, 3.00mmol) were added to a reaction flask, dissolved by stirring, and reacted under reflux for 5 hours under nitrogen. And (3) after the temperature of the system is reduced to room temperature, filtering the system by using kieselguhr, concentrating filtrate, recrystallizing the filtrate by using ethyl acetate, performing suction filtration, and leaching the filtrate by using methanol to obtain recrystallized solid, so that the compound 2(15.84g, the yield is 76%) is obtained, and the purity of the solid is not less than 99.89% by HPLC (high performance liquid chromatography). Mass spectrum m/z: 694.2971 (theoretical value: 694.2984). Theoretical element content (%) C51H38N2O: c, 88.15; h, 5.51; and N, 4.03. Measured elemental content (%): c, 88.21; h, 5.47; and N, 3.98.
Synthesis example 2: preparation of Compound 6
Figure BDA0003488815610000331
Compound 6(14.23g) was obtained by the same preparation method as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6 and e-2 was replaced with equimolar e-6; the HPLC purity is more than or equal to 99.85 percent. Mass spectrum m/z: 658.3002 (theoretical value: 658.2984). Theoretical element content (%) C48H38N2O: c, 87.51; h, 5.81; and N, 4.25. Measured elemental content (%): c, 87.46; h, 5.78; and N, 4.30.
Synthetic example 3: preparation of Compound 25
Figure BDA0003488815610000332
Compound 25(17.12g) was obtained by the same preparation method as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-25, b-2 was replaced with equimolar b-25, and d-2 was replaced with equimolar a-25; the HPLC purity is more than or equal to 99.81 percent.Mass spectrum m/z: 826.3397 (theoretical value: 826.3382). Theoretical element content (%) C60H46N2S: c, 87.13; h, 5.61; and N, 3.39. Measured elemental content (%): c, 87.08; h, 5.57; n, 3.44.
Synthetic example 4: preparation of Compound 44
Figure BDA0003488815610000341
Compound 44(17.12g) was obtained by the same preparation method as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-44, e-2 was replaced with equimolar e-44, and g-2 was replaced with equimolar g-44; the HPLC purity is more than or equal to 99.86 percent. Mass spectrum m/z: 781.3082 (theoretical value: 781.3093). Theoretical element content (%) C57H39N3O: c, 87.55; h, 5.03; n, 5.37. Measured elemental content (%): c, 87.61; h, 4.97; n, 5.41.
Synthesis example 5: preparation of Compound 49
Figure BDA0003488815610000342
Compound 49(17.79g) was obtained in the same manner as in Synthesis example 1 except that g-2 in Synthesis example 1 was replaced with equimolar g-49; the HPLC purity is more than or equal to 99.82 percent. Mass spectrum m/z: 846.3626 (theoretical value: 846.3610). Theoretical element content (%) C63H46N2O: c, 89.33; h, 5.47; and N, 3.31. Measured elemental content (%): c, 89.28; h, 5.50; and N, 3.28.
Synthetic example 6: preparation of Compound 56
Figure BDA0003488815610000343
Synthesis example 1 was repeated except that a-2 was replaced with equimolar a-6, b-2 was replaced with equimolar b-56, d-2 was replaced with equimolar d-56, e-2 was replaced with equimolar b-56, and g-2 was replaced with equimolar g-49According to the same production method as in Synthesis example 1, Compound 56(20.81g) was obtained; the HPLC purity is more than or equal to 99.78 percent. Mass spectrum m/z: 962.5191 (theoretical value: 962.5175). Theoretical element content (%) C71H66N2O: c, 88.53; h, 6.91; and N, 2.91. Measured elemental content (%): c, 88.49; h, 6.88; and N, 2.95.
Synthetic example 7: preparation of Compound 60
Figure BDA0003488815610000344
Preparation of intermediate c-60:
the same preparation method as that for intermediate c-2 in synthetic example 1 was followed except for replacing b-2 in synthetic example 1 with equimolar b-60 to give intermediate c-60(23.97g), mass m/z: 315.1096 (theoretical value: 315.1082).
Preparation of compound 60:
toluene (400mL), g-60(11.64g, 30.00mmol), c-60(20.82, 66.00mmol), tris (dibenzylideneacetone) dipalladium (0.82g, 0.90mmol), potassium tert-butoxide (13.47, 120.00mmol) and BINAP (3.74g, 6.00mmol) were added to a reaction flask, dissolved by stirring, and reacted under reflux for 5 hours under nitrogen. After the temperature of the system is reduced to room temperature, filtering with diatomite, concentrating the filtrate, recrystallizing with ethyl acetate, filtering, and leaching with methanol to obtain a recrystallized solid, thus obtaining a compound 60(20.06g, yield 78%); the HPLC purity is more than or equal to 99.79 percent. Mass spectrum m/z: 856.2957 (theoretical value: 856.2946). Theoretical element content (%) C60H44N2S2: c, 84.08; h, 5.17; and N, 3.27. Measured elemental content (%): c, 84.12; h, 5.20; and N, 3.23.
Synthesis example 8: preparation of Compound 71
Figure BDA0003488815610000351
Synthesis example 1 in which a-2 was replaced with equimolar a-44, b-2 was replaced with equimolar b-71, d-2 was replaced with equimolar d-71, and e-2 was replaced withSubstitution of equimolar e-71, g-2 for equimolar g-49 was carried out in the same manner as in Synthesis example 1 to give Compound 71(16.83 g); the HPLC purity is more than or equal to 99.81 percent. Mass spectrum m/z: 824.3211 (theoretical value: 824.3225). Theoretical element content (%) C60H44N2S: c, 87.34; h, 5.38; and N, 3.40. Measured elemental content (%): c, 87.29; h, 5.43; and N, 3.39.
Synthetic example 9: preparation of Compound 100
Figure BDA0003488815610000352
Compound 100(16.98g) was obtained by the same preparation method as in Synthesis example 1 except that b-2 was replaced with equimolar e-2 and g-2 was replaced with equimolar g-100 in Synthesis example 1; the HPLC purity is more than or equal to 99.82 percent. Mass spectrum m/z: 734.3285 (theoretical value: 734.3297). Theoretical element content (%) C54H42N2O: c, 88.25; h, 5.76; and N, 3.81. Measured elemental content (%): c, 88.30; h, 5.75; n, 3.79.
Synthetic example 10: preparation of Compound 102
Figure BDA0003488815610000361
Compound 102(14.67g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-44, b-2 was replaced with equimolar b-102, d-2 was replaced with equimolar a-44, e-2 was replaced with equimolar b-60, and g-2 was replaced with equimolar g-102; the HPLC purity is more than or equal to 99.81 percent. Mass spectrum m/z: 708.2612 (theoretical value: 708.2599). Theoretical element content (%) C51H36N2S: c, 86.41; h, 5.12; and N, 3.95. Measured elemental content (%): c, 86.37; h, 5.09; and N, 4.01.
Synthetic example 11: preparation of Compound 108
Figure BDA0003488815610000362
Compound 108(17.69g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-44, b-2 was replaced with equimolar e-2, e-2 was replaced with equimolar e-108, and g-2 was replaced with equimolar g-108; the HPLC purity is more than or equal to 99.78 percent. Mass spectrum m/z: 920.3776 (theoretical value: 920.3767). Theoretical element content (%) C69H48N2O: c, 89.97; h, 5.25; and N, 3.04. Measured elemental content (%): c, 90.01; h, 5.27; and N, 2.99.
Synthetic example 12: preparation of Compound 126
Figure BDA0003488815610000363
Preparation of intermediate c-126:
the same preparation method as that for intermediate c-2 in synthetic example 1 was followed except that a-2 in synthetic example 1 was replaced with equimolar a-44, b-2 was replaced with equimolar b-60, and g-2 was replaced with equimolar g-126, to give intermediate c-126(24.13g), mass m/z: 313.0938 (theoretical value: 313.0925).
Preparation of compound 126:
compound 126(18.68g) was obtained by the same preparation method as in Synthesis example 7 except that g-60 in Synthesis example 7 was replaced with equimolar g-126; the HPLC purity is more than or equal to 99.75 percent. Mass spectrum m/z: 928.2933 (theoretical value: 928.2946). Theoretical element content (%) C66H44N2S2: c, 85.31; h, 4.77; and N, 3.01. Measured elemental content (%): c, 85.26; h, 4.81; and N, 2.98.
Synthetic example 13: preparation of Compound 136
Figure BDA0003488815610000371
Compound 136(17.81g) was obtained by the same preparation method as in Synthesis example 1 except that e-2 in Synthesis example 1 was replaced with equimolar b-2; HPLCThe purity is more than or equal to 99.87 percent. Mass spectrum m/z: 770.3309 (theoretical value: 770.3297). Theoretical element content (%) C57H42N2O: c, 88.80; h, 5.49; and N, 3.63. Measured elemental content (%): c, 88.75; h, 5.53; and N, 3.66.
Synthesis example 14: preparation of Compound 137
Figure BDA0003488815610000372
Compound 137(17.81g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-137, d-2 was replaced with equimolar d-137, e-2 was replaced with equimolar b-137, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.85 percent. Mass spectrum m/z: 780.3941 (theoretical value: 780.3925). Theoretical element content (%) C57H32D10N2O: c, 87.66; h, 6.71; and N, 3.59. Measured elemental content (%): c, 87.71; h, 67; and N, 3.62.
Synthetic example 15: preparation of Compound 140
Figure BDA0003488815610000373
Compound 140(20.39g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-140, d-2 was replaced with equimolar d-56, e-2 was replaced with equimolar b-140, and g-2 was replaced with equimolar g-140; the HPLC purity is more than or equal to 99.77 percent. Mass spectrum m/z: 930.4412 (theoretical value: 930.4425). Theoretical element content (%) C69H42D8N2O: c, 89.00; h, 6.28; and N, 3.01. Measured elemental content (%): c, 88.97; h, 6.31; and N, 2.98.
Synthetic example 16: preparation of Compound 142
Figure BDA0003488815610000381
Compound 142(17.65g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-142, b-2 was replaced with equimolar b-142, d-2 was replaced with equimolar d-142, e-2 was replaced with equimolar b-142, and g-2 was replaced with equimolar g-100; HPLC purity is more than or equal to 99.84%. Mass spectrum m/z: 794.3314 (theoretical value: 794.3297). Theoretical element content (%) C59H42N2O: c, 89.14; h, 5.33; and N, 3.52. Measured elemental content (%): c, 89.09; h, 5.37; n, 3.54.
Synthetic example 17: preparation of Compound 146
Figure BDA0003488815610000382
Compound 146(16.76g) was obtained in the same manner as in Synthesis example 1 except that b-2 in Synthesis example 1 was replaced with equimolar b-146 and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.87 percent. Mass spectrum m/z: 734.3282 (theoretical value: 734.3297). Theoretical element content (%) C54H42N2O: c, 88.25; h, 5.76; and N, 3.81. Measured elemental content (%): c, 88.31; h, 5.74; n, 3.79.
Synthetic example 18: preparation of Compound 156
Figure BDA0003488815610000383
Compound 156(19.41g) was obtained in the same manner as in Synthesis example 1 except that b-2 in Synthesis example 1 was replaced with equimolar b-71, d-2 was replaced with equimolar d-56, e-2 was replaced with equimolar b-71, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.83 percent. Mass spectrum m/z: 850.3941 (theoretical value: 850.3923). Theoretical element content (%) C63H50N2O: c, 88.91; h, 5.92; and N, 3.29. Measured elemental content (%): c, 88.86; h, 5.90; n, 3.34.
Synthetic example 19: preparation of Compound 180
Figure BDA0003488815610000391
Compound 180(20.31g) was obtained in the same manner as in Synthesis example 1 except that b-2 in Synthesis example 1 was replaced with equimolar b-180, d-2 was replaced with equimolar d-56, e-2 was replaced with equimolar b-180, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.79 percent. Mass spectrum m/z: 952.4127 (theoretical value: 952.4141). Theoretical element content (%) C69H52N4O: c, 86.94; h, 5.50; and N, 5.88. Measured elemental content (%): c, 86.98; h, 5.46; and N, 5.91.
Synthesis example 20: preparation of compound 186
Figure BDA0003488815610000392
Compound 186(17.35g) was obtained by the same preparation method as in Synthesis example 1 except that g-2 in Synthesis example 1 was replaced with equimolar g-102; the HPLC purity is more than or equal to 99.86 percent. Mass spectrum m/z: 770.3281 (theoretical value: 770.3297). Theoretical element content (%) C57H42N2O: c, 88.80; h, 5.49; and N, 3.63. Measured elemental content (%): c, 88.76; h, 5.51; n, 3.67.
Synthetic example 21: preparation of Compound 187
Figure BDA0003488815610000393
Compound 187(19.42g) was obtained by the same preparation method as in Synthesis example 1 except that d-2 in Synthesis example 1 was replaced with equimolar d-187 and e-2 was replaced with equimolar b-2; the HPLC purity is more than or equal to 99.76 percent. Mass spectrum m/z: 898.3932 (theoretical value: 898.3923). Theoretical element content (%) C67H50N2O: c, 89.50; h, 5.61; and N, 3.12. Measured elemental content (%): c, 89.47; h, 5.65; and N, 3.09.
Synthetic example 22: preparation of Compound 192
Figure BDA0003488815610000394
Compound 192(15.52g) was obtained according to the same preparation method as in synthesis example 1 except that intermediate h-2 in synthesis example 1 was replaced with an equimolar amount of intermediate h-146 and intermediate f-2 was replaced with an equimolar amount of intermediate c-2; the HPLC purity is more than or equal to 99.82 percent. Mass spectrum m/z: 698.3285 (theoretical value: 698.3297). Theoretical element content (%) C51H42N2O: c, 87.65; h, 6.06; and N, 4.01. Measured elemental content (%): c, 87.63; h, 6.11; and N, 3.96.
Synthetic example 23: preparation of Compound 202
Figure BDA0003488815610000401
Compound 202(21.14g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-142, b-2 was replaced with equimolar b-202, d-2 was replaced with equimolar a-142, e-2 was replaced with equimolar b-2, and g-2 was replaced with equimolar g-100; HPLC purity is more than or equal to 99.74 percent. Mass spectrum m/z: 926.4249 (theoretical value: 926.4236). Theoretical element content (%) C69H54N2O: c, 89.38; h, 5.87; and N, 3.02. Measured elemental content (%): c, 89.42; h, 5.91; and N, 2.97.
Synthetic example 24: preparation of Compound 230
Figure BDA0003488815610000402
Compound 230 (19) was obtained in the same manner as in Synthesis example 1, except that a-2 in Synthesis example 1 was replaced with equimolar a-230, b-2 was replaced with equimolar b-230, d-2 was replaced with equimolar d-230, e-2 was replaced with equimolar b-2, and g-2 was replaced with equimolar g-10091 g); the HPLC purity is more than or equal to 99.76 percent. Mass spectrum m/z: 908.3412 (theoretical value: 908.3403). Theoretical element content (%) C67H44N2O2: c, 88.52; h, 4.88; and N, 3.08. Measured elemental content (%): c, 88.49; h, 4.92; n, 3.11.
Synthetic example 25: preparation of Compound 231
Figure BDA0003488815610000403
Compound 231(18.43g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-230, b-2 was replaced with equimolar e-2, e-2 was replaced with equimolar e-231, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.85 percent. Mass spectrum m/z: 818.3288 (theoretical value: 818.3297). Theoretical element content (%) C61H42N2O: c, 89.46; h, 5.17; and N, 3.42. Measured elemental content (%): c, 89.43; h, 5.22; and N, 3.39.
Synthetic example 26: preparation of Compound 257
Figure BDA0003488815610000411
Compound 257(16.79g) was obtained according to the same preparation method as that of Synthesis example 1, except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-257, d-2 was replaced with equimolar d-257, e-2 was replaced with equimolar b-257, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.83 percent. Mass spectrum m/z: 822.4019 (theoretical value: 822.4008). Theoretical element content (%) C59H54N2S: c, 86.09; h, 6.61; and N, 3.40. Measured elemental content (%): c, 86.11; h, 6.59; n, 3.43.
Synthetic example 27: preparation of compound 279
Figure BDA0003488815610000412
Compound 279(20.74g) was obtained by the same preparation method as in Synthesis example 1 except that b-2 in Synthesis example 1 was replaced with equimolar b-279, d-2 was replaced with equimolar d-279, e-2 was replaced with equimolar b-279, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.75 percent. Mass spectrum m/z: 986.5585 (theoretical value: 986.5573). Theoretical element content (%) C71H74N2S: c, 86.36; h, 7.55; n, 2.84. Measured elemental content (%): c, 86.41; h, 7.56; n, 2.81.
Synthetic example 28: preparation of Compound 285
Figure BDA0003488815610000413
Compound 285(22.67g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-285, d-2 was replaced with equimolar d-285, e-2 was replaced with equimolar b-285, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.71 percent. Mass spectrum m/z: 1110.3996 (theoretical value: 1110.4008). Theoretical element content (%) C83H54N2S: c, 89.70; h, 4.90; and N, 2.52. Measured elemental content (%): c, 89.67; h, 4.86; and N, 2.55.
Synthetic example 29: preparation of Compound 336
Figure BDA0003488815610000421
Compound 336(19.4g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-230, b-2 was replaced with equimolar b-336, d-2 was replaced with equimolar d-279, e-2 was replaced with equimolar b-336, and g-2 was replaced with equimolar g-336; the HPLC purity is more than or equal to 99.76 percent. Mass spectrum m/z: 964.3842 (theoretical value: 964.3851). Theoretical element content (%) C71H52N2S: c, 88.35; h, 5.43; and N, 2.90. Measured elemental content (%): c, 88.38; h, 5.39; and N,2.88。
Synthetic example 30: preparation of compound 376
Figure BDA0003488815610000422
Compound 376(16.49g) was obtained by the same preparation method as in Synthesis example 1 except that d-2 was replaced with equimolar d-279 and g-2 was replaced with equimolar g-102; the HPLC purity is more than or equal to 99.85 percent. Mass spectrum m/z: 784.2924 (theoretical value: 784.2912). Theoretical element content (%) C57H40N2S: c, 87.21; h, 5.14; and N, 3.57. Measured elemental content (%): c, 87.17; h, 5.16; and N, 3.61.
Synthetic example 31: preparation of Compound 391
Figure BDA0003488815610000423
Compound 391(16.65g) was obtained in the same manner as in Synthesis example 1 except that g-2 in Synthesis example 1 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.86 percent. Mass spectrum m/z: 770.3284 (theoretical value: 770.3297). Theoretical element content (%) C57H42N2O: c, 88.80; h, 5.49; and N, 3.63. Measured elemental content (%): c, 88.75; h, 5.52; and N, 3.61.
Synthetic example 32: preparation of Compound 435
Figure BDA0003488815610000431
Compound 435(17.36g) was obtained in the same manner as in Synthesis example 1 except that d-2 in Synthesis example 1 was replaced with equimolar d-56, e-2 was replaced with equimolar b-2, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.82 percent. Mass spectrum m/z: 814.2665 (theoretical value: 814.2654). Theoretical element content (%) C57H38N2O2S: c, 84.00; h, 4.70; n, 3.44. Measured elemental content(%):C,83.98;H,4.67;N,3.47。
Synthetic example 33: preparation of compound 441
Figure BDA0003488815610000432
Compound 441(19.16g) was obtained in the same manner as in Synthesis example 1 except that b-2 was replaced with equimolar b-441 and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.81 percent. Mass spectrum m/z: 862.3398 (theoretical value: 862.3382). Theoretical element content (%) C63H46N2S: c, 87.67; h, 5.37; and N, 3.25. Measured elemental content (%): c, 87.71; h, 5.40; and N, 3.22.
Synthesis example 34: preparation of Compound 505
Figure BDA0003488815610000433
Compound 505(15.96g) was obtained in the same manner as in Synthesis example 1 except that b-2 in Synthesis example 1 was replaced with equimolar e-108, d-2 was replaced with equimolar d-71, e-2 was replaced with equimolar b-137, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.89 percent. Mass spectrum m/z: 699.3288 (theoretical value: 699.3298). Theoretical element content (%) C51H33D5N2O: c, 87.52; h, 6.19; and N, 4.00. Measured elemental content (%): c, 87.49; h, 6.24; and N, 3.96.
Synthetic example 35: preparation of Compound 510
Figure BDA0003488815610000441
Compound 510(18.23g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-510, d-2 was replaced with equimolar d-510, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.85 percent.Mass spectrum m/z: 820.3443 (theoretical value: 820.3454). Theoretical element content (%) C61H44N2O: c, 89.24; h, 5.40; n, 3.41. Measured elemental content (%): c, 89.27; h, 5.36; and N, 3.38.
Synthetic example 36: preparation of Compound 513
Figure BDA0003488815610000442
Compound 513(17.41g) was obtained in the same manner as in Synthesis example 1 except that d-2 in Synthesis example 1 was replaced with equimolar amount of d-513; the HPLC purity is more than or equal to 99.83 percent. Mass spectrum m/z: 794.3306 (theoretical value: 794.3297). Theoretical element content (%) C59H42N2O: c, 89.14; h, 5.33; and N, 3.52. Measured elemental content (%): c, 89.19; h, 5.28; and N, 3.49.
Synthetic example 37: preparation of Compound 517
Figure BDA0003488815610000443
Compound 517(21.32g) was obtained by the same preparation method as in Synthesis example 1 except that d-2 in Synthesis example 1 was replaced with equimolar d-187 and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.78 percent. Mass spectrum m/z: 934.3935 (theoretical value: 934.3923). Theoretical element content (%) C70H50N2O: c, 89.90; h, 5.39; and N, 3.00. Measured elemental content (%): c, 89.88; h, 5.44; and N, 2.96.
Synthetic example 38: preparation of Compound 560
Figure BDA0003488815610000451
Compound 560(18.13g) was obtained in the same manner as in Synthesis example 1 except that d-2 in Synthesis example 1 was replaced with equimolar d-560 and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.83 percent. Mass spectrum m/z:850.3371 (theoretical value: 850.3382). Theoretical element content (%) C62H46N2S: c, 87.49; h, 5.45; and N, 3.29. Measured elemental content (%): c, 87.52; h, 5.41; n, 3.43.
Synthetic example 39: preparation of Compound 570
Figure BDA0003488815610000452
Compound 570(19.71g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-6, b-2 was replaced with equimolar b-60, and g-2 was replaced with equimolar g-100; the HPLC purity is more than or equal to 99.81 percent. Mass spectrum m/z: 875.3342 (theoretical value: 875.3334). Theoretical element content (%) C63H45N3S: c, 86.37; h, 5.18; and N, 4.80. Measured elemental content (%): c, 86.35; h, 5.21; n, 4.77.
Synthetic example 40: preparation of Compound 660
Figure BDA0003488815610000453
Compound 660(16.16g) was obtained in the same manner as in Synthesis example 1 except that a-2 in Synthesis example 1 was replaced with equimolar a-230, b-2 was replaced with equimolar b-60, d-2 was replaced with equimolar d-71, and g-2 was replaced with equimolar g-102; the HPLC purity is more than or equal to 99.87 percent. Mass spectrum m/z: 708.2585 (theoretical value: 708.2599). Theoretical element content (%) C51H36N2S: c, 86.41; h, 5.12; and N, 3.95. Measured elemental content (%): c, 86.36; h, 5.09; and N, 4.01.
Device examples 1 to 40
The ITO glass substrate is ultrasonically cleaned for 2 times and 20 minutes each time by 5% glass cleaning solution, and then ultrasonically cleaned for 2 times and 10 minutes each time by deionized water. Ultrasonic cleaning with acetone and isopropanol for 20 min, and oven drying at 120 deg.C. HI-1 is evaporated on the ITO substrate in vacuum to be used as a hole injection layer, and the evaporation thickness is 15 nm; vacuum evaporating the compound 2 of the invention on the hole injection layer to form a hole transport layer, wherein the evaporation thickness is 80 nm; vacuum evaporating RH: RD 98:2 (mass ratio) on the hole transport layer to form a light emitting layer, wherein the evaporation thickness is 20 nm; vacuum evaporating ET-1 on the light-emitting layer to form an electron transport layer, wherein the evaporation thickness is 30 nm; evaporating LiF on the electron transport layer in vacuum to form an electron injection layer, wherein the evaporation thickness is 1 nm; al was vacuum-deposited on the electron injection layer as a cathode, and the deposition thickness was 70 nm.
Figure BDA0003488815610000461
Device embodiments 2 to 40: an organic electroluminescent device was produced by using the same procedure as in device example 1 except that the compound 2 of the present invention in device example 1 was replaced with the compounds 6, 25, 44, 49, 56, 60, 71, 100, 102, 108, 126, 136, 137, 140, 142, 146, 156, 180, 186, 187, 192, 202, 230, 231, 257, 279, 285, 336, 376, 391, 435, 441, 505, 510, 513, 517, 560, 570, 660, respectively, as a hole transporting material.
Comparative examples 1 to 2: an organic electroluminescent device was produced by using the same procedure as in device example 1 except that the compound 2 of the present invention in device example 1 was replaced with the compound 1 and the compound 2 as a hole transport layer, respectively.
The test software, computer, K2400 digital source meter manufactured by Keithley corporation, usa, and PR788 spectral scanning luminance meter manufactured by Photo Research corporation, usa were combined into a combined IVL test system to test the luminous efficiency of the organic electroluminescent device. The lifetime was measured using the M6000 OLED lifetime test system from McScience. The environment of the test is atmospheric environment, and the temperature is room temperature.
The results of the light emission characteristic test of the obtained organic electroluminescent device are shown in table 1. Table 1 shows the results of the test of the light emitting characteristics of the organic electroluminescent devices prepared from the compounds prepared in the inventive examples and the comparative materials.
Figure BDA0003488815610000462
Figure BDA0003488815610000471
Device examples 41 to 40
The ITO glass substrate is ultrasonically cleaned for 2 times and 20 minutes each time by 5% glass cleaning solution, and then ultrasonically cleaned for 2 times and 10 minutes each time by deionized water. Ultrasonic cleaning with acetone and isopropanol for 20 min, and oven drying at 120 deg.C. HI-1 is evaporated on the ITO substrate in vacuum to be used as a hole injection layer, and the evaporation thickness is 15 nm; evaporating HT-1 on the hole injection layer in vacuum to form a hole transmission layer, wherein the evaporation thickness is 50 nm; vacuum evaporating the compound 44 of the invention on the hole transport layer to form a light-emitting auxiliary layer with the thickness of 40nm, and vacuum evaporating RH: RD (98: 2) on the light-emitting auxiliary layer to form a light-emitting layer with the thickness of 20 nm; vacuum evaporating ET-1 on the light-emitting layer to form an electron transport layer, wherein the evaporation thickness is 30 nm; evaporating LiF on the electron transport layer in vacuum to form an electron injection layer, wherein the evaporation thickness is 1 nm; al was vacuum-deposited on the electron injection layer as a cathode, and the deposition thickness was 70 nm.
Figure BDA0003488815610000481
Device embodiments 2 to 40: an organic electroluminescent device was produced by using the same procedure as in device example 41 except that the compound 44 of the present invention in device example 1 was replaced with the compound 136, 156, 230, 231, 279, 336, 435, 513, 517, 570 of the present invention as a light-emitting auxiliary layer material, respectively.
Comparative examples 1 to 2: an organic electroluminescent device was produced by using the same procedure as in device example 41 except that the compound 44 of the present invention in device example 41 was replaced with the compound 1 and the compound 2, respectively, as a light-emitting auxiliary layer material.
The test software, computer, K2400 digital source meter manufactured by Keithley corporation, usa, and PR788 spectral scanning luminance meter manufactured by Photo Research corporation, usa were combined into a combined IVL test system to test the luminous efficiency of the organic electroluminescent device. The lifetime was measured using the M6000 OLED lifetime test system from McScience. The environment of the test is atmospheric environment, and the temperature is room temperature.
The results of the light emission characteristic test of the obtained organic electroluminescent device are shown in table 2. Table 2 shows the results of the test of the light emitting characteristics of the organic electroluminescent devices prepared by the compounds prepared in the inventive examples and the comparative materials.
Figure BDA0003488815610000482
It can be seen from tables 1 and 2 that when the benzidine derivative of the present invention is applied to an organic electroluminescent device as a hole transport layer material and a light-emitting auxiliary layer material, the light-emitting efficiency and the service life of the device are significantly improved. The benzidine derivative provided by the invention has good hole mobility, can balance the carrier transmission in the device, and improves the luminous efficiency of the device, and meanwhile, the benzidine derivative has good thermal stability and film-forming property, and can effectively prolong the service life of the device.
It should be understood that the present invention has been particularly described with reference to particular embodiments thereof, but that various changes in form and details may be made therein by those skilled in the art without departing from the principles of the invention and, therefore, within the scope of the invention.

Claims (10)

1. A benzidine derivative is characterized in that the benzidine derivative has the structure shown as the following,
Figure FDA0003488815600000011
wherein, Ar is1Selected from the group consisting of the structures represented by chemical formula 2,
Figure FDA0003488815600000012
the ring A is selected from any one of the structures shown below,
Figure FDA0003488815600000013
ar is2~Ar4At least one of them is selected from the group consisting of the structure of chemical formula 3, and the others are the same or different and selected from any one of chemical formula 2, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C1-C25 heterocycloalkyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C25 alicyclic ring and C2-C30 fused ring group, — N Ra and (Rb);
the Ra and the Rb are the same or different and are selected from any one of substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 alicyclic ring, fused ring group of C6-C30 aromatic ring and substituted or unsubstituted C2-C30 heteroaryl;
Figure FDA0003488815600000014
x is selected from O or S;
the R is1、R2、R3The same or different groups are selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C3-C25 heterocyclic alkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 alicyclic ring and C6-C30 aromatic ring fused ring group, substituted or unsubstituted C2-C30 heteroarylAny one of the above;
n is1Selected from 0,1, 2,3 or 4; when n is1Greater than 1, two or more R1Are the same or different from each other, or adjacent R1May form a substituted or unsubstituted ring;
n is2Selected from 0,1, 2,3, 4,5, 6 or 7; when n is2Greater than 1, two or more R2Are the same or different from each other;
n is4Selected from 0,1, 2,3, 4,5, 6 or 7; when n is4Greater than 1, two or more R3Are the same or different from each other, or adjacent R3May form a substituted or unsubstituted ring;
said L1~L4Any one of the same or different single bonds, substituted or unsubstituted C3-C25 alicyclic group, substituted or unsubstituted C6-C30 arylene group, substituted or unsubstituted C3-C30 alicyclic group, substituted or unsubstituted C6-C30 aromatic ring fused cyclic group and substituted or unsubstituted C2-C30 heteroarylene group;
n is3Selected from 1,2, 3 or 4; when n3 is greater than 1, two or more
Figure FDA0003488815600000021
The same or different from each other.
2. The benzidine derivative according to claim 1, wherein the benzidine derivative is selected from any one of chemical formulas 1-1 to 1-8,
Figure FDA0003488815600000022
the R is1The same or different is selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutylAny one of a phenyl group, a substituted or unsubstituted cyclopentyl group, a substituted or unsubstituted cyclohexyl group, a substituted or unsubstituted cyclopentenyl group, a substituted or unsubstituted cyclohexenyl group, a substituted or unsubstituted adamantyl group, a substituted or unsubstituted norbornane group, a substituted or unsubstituted piperidyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthryl group, a substituted or unsubstituted phenanthryl group, a substituted or unsubstituted triphenylene group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted fluorenyl group, and a substituted or unsubstituted carbazolyl group;
n is1Selected from 0,1, 2,3 or 4; when n is1Greater than 1, two or more R1Are the same or different from each other, or adjacent R1May form a substituted or unsubstituted ring therebetween.
3. The dianiline derivative of claim 1, wherein the chemical formula 3 is selected from any one of the following structures,
Figure FDA0003488815600000031
X0any one selected from O, S, C (Rc) (Rd) and N (Re);
the R is3Rc, Rd are the same or different and are selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted t-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornanyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenylAny one of substituted or unsubstituted phenanthryl, substituted or unsubstituted triphenylene, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, and substituted or unsubstituted carbazolyl;
the Re is selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, Any one of substituted or unsubstituted carbazolyl groups.
4. The dianiline derivative of claim 1 or 3, wherein the chemical formula 3 is selected from any one of the following structures,
Figure FDA0003488815600000032
Figure FDA0003488815600000041
5. the dianiline derivative of claim 1, wherein the chemical formula 2 is selected from any one of the following structures,
Figure FDA0003488815600000042
6. the dianiline derivative of claim 1, wherein Ar is selected from the group consisting of2~Ar4At least one of them is selected from the group consisting of the structures represented by chemical formula 3, and the remaining same or different are selected from any one of chemical formula 2, a substituted or unsubstituted methyl group, a substituted or unsubstituted ethyl group, a substituted or unsubstituted n-propyl group, a substituted or unsubstituted isopropyl group, a substituted or unsubstituted isobutyl group, a substituted or unsubstituted t-butyl group, a substituted or unsubstituted cyclopropyl group, a substituted or unsubstituted cyclobutyl group, a substituted or unsubstituted cyclopentyl group, a substituted or unsubstituted cyclohexyl group, a substituted or unsubstituted cyclopentenyl group, a substituted or unsubstituted cyclohexenyl group, a substituted or unsubstituted adamantyl group, a substituted or unsubstituted norbornyl group, a substituted or unsubstituted piperidyl group, or the structures represented below,
Figure FDA0003488815600000043
Figure FDA0003488815600000051
said Y is1、Y2The same or different is selected from O, S, C (Rf) (Rg) and N (Rh);
the R is4、R5、R6、R7Rf, Rg are the same or different and are selected from hydrogen, deuterium, cyano, halogen, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted t-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroaryl, or substituted heteroaryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroaryl, or substituted heteroaryl, or substituted or unsubstituted heteroaryl, or substituted or substituted or substituted or substituted or substituted or substituted or substituted or,Any one of substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornanyl, substituted or unsubstituted piperidyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthryl, substituted or unsubstituted phenanthryl, substituted or unsubstituted triphenylene, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, and substituted or unsubstituted carbazolyl;
the Rh is selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted isopropyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted cyclopropyl, substituted or unsubstituted cyclobutyl, substituted or unsubstituted cyclopentyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted cyclopentenyl, substituted or unsubstituted cyclohexenyl, substituted or unsubstituted adamantyl, substituted or unsubstituted norbornyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthrenyl, substituted or unsubstituted triphenylenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted fluorenyl, Any one of substituted or unsubstituted carbazolyl groups;
m is1Selected from 0,1, 2,3, 4 or 5; m is2Selected from 0,1, 2,3 or 4; m is3Selected from 0,1, 2,3, 4,5, 6 or 7; m is4Selected from 0,1, 2,3, 4,5, 6,7, 8 or 9; m is5Selected from 0,1, 2,3, 4,5, 6,7 or 8; when m is1、m2、m3、m4、m5Greater than 1, two or more R4Are the same or different from each other, two or more R5Are the same or different from each other, or adjacent R4May form a substituted or unsubstituted ring, adjacent R5May form a substitution or non-substitution betweenA substituted ring;
said L0Is selected from any one of single bond, substituted or unsubstituted arylene of C6-C18 and substituted or unsubstituted heteroarylene of C2-C18.
7. The dianiline derivative of claim 1, wherein Ar is selected from the group consisting of2~Ar4At least one of them is selected from the group consisting of the structures represented by chemical formula 3, and the remaining same or different are selected from the group consisting of chemical formula 2, a substituted or unsubstituted methyl group, a substituted or unsubstituted ethyl group, a substituted or unsubstituted n-propyl group, a substituted or unsubstituted isopropyl group, a substituted or unsubstituted isobutyl group, a substituted or unsubstituted t-butyl group, a substituted or unsubstituted cyclopropyl group, a substituted or unsubstituted cyclobutyl group, a substituted or unsubstituted cyclopentyl group, a substituted or unsubstituted cyclohexyl group, a substituted or unsubstituted cyclopentenyl group, a substituted or unsubstituted cyclohexenyl group, or any one of the structures represented below,
Figure FDA0003488815600000052
Figure FDA0003488815600000061
Figure FDA0003488815600000071
Figure FDA0003488815600000081
8. the dianiline derivative of claim 1, wherein L is1~L4The same or different is selected from a single bond or any one of the structures shown below,
Figure FDA0003488815600000082
wherein, R is8、R9Any one of the same or different hydrogen, deuterium, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C6-C18 aryl and substituted or unsubstituted C2-C12 heteroaryl;
k is1Identical or different from 0,1, 2,3 or 4, k2Identical or different from 0,1, 2,3, 4,5 or 6, k3Identical or different from 0,1, 2,3, 4,5, 6,7 or 8, k4The same or different is selected from 0,1, 2 or 3; when k is1、k2、k3、k4Greater than 1, two or more R9R being identical or different from each other, or adjacent to each other9May form a substituted or unsubstituted ring therebetween.
9. A benzidine derivative according to claim 1, wherein the benzidine derivative has any one of the structures shown below,
Figure FDA0003488815600000091
Figure FDA0003488815600000101
Figure FDA0003488815600000111
Figure FDA0003488815600000121
Figure FDA0003488815600000131
Figure FDA0003488815600000141
Figure FDA0003488815600000151
Figure FDA0003488815600000161
Figure FDA0003488815600000171
Figure FDA0003488815600000181
Figure FDA0003488815600000191
Figure FDA0003488815600000201
Figure FDA0003488815600000211
Figure FDA0003488815600000221
10. an organic electroluminescent device comprising an anode, a cathode, and an organic layer between and outside the anode and the cathode, wherein the organic layer comprises a hole transporting region, a light emitting layer, and an electron transporting region, and wherein the hole transporting region contains one or more of the benzidine derivatives according to any one of claims 1 to 9.
CN202210090065.4A 2022-01-25 2022-01-25 Benzidine derivative and organic electroluminescent device thereof Active CN114394949B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210090065.4A CN114394949B (en) 2022-01-25 2022-01-25 Benzidine derivative and organic electroluminescent device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210090065.4A CN114394949B (en) 2022-01-25 2022-01-25 Benzidine derivative and organic electroluminescent device thereof

Publications (2)

Publication Number Publication Date
CN114394949A true CN114394949A (en) 2022-04-26
CN114394949B CN114394949B (en) 2023-11-10

Family

ID=81232801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210090065.4A Active CN114394949B (en) 2022-01-25 2022-01-25 Benzidine derivative and organic electroluminescent device thereof

Country Status (1)

Country Link
CN (1) CN114394949B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115417806A (en) * 2022-09-30 2022-12-02 长春海谱润斯科技股份有限公司 Carbazole compound and organic electroluminescent device thereof
WO2023160121A1 (en) * 2022-02-25 2023-08-31 陕西莱特光电材料股份有限公司 Organic compound, electronic element comprising same, and electronic device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014021569A1 (en) * 2012-08-01 2014-02-06 Sk Chemicals Co., Ltd. Compound for organic electroluminescent device and organic electroluminescent device including the same
CN110003090A (en) * 2019-04-02 2019-07-12 北京诚志永华显示科技有限公司 Indene derivative, the organic electroluminescence device containing indene derivative
CN113717057A (en) * 2020-05-26 2021-11-30 三星显示有限公司 Amine compound and organic light emitting device including the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014021569A1 (en) * 2012-08-01 2014-02-06 Sk Chemicals Co., Ltd. Compound for organic electroluminescent device and organic electroluminescent device including the same
CN110003090A (en) * 2019-04-02 2019-07-12 北京诚志永华显示科技有限公司 Indene derivative, the organic electroluminescence device containing indene derivative
CN113717057A (en) * 2020-05-26 2021-11-30 三星显示有限公司 Amine compound and organic light emitting device including the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023160121A1 (en) * 2022-02-25 2023-08-31 陕西莱特光电材料股份有限公司 Organic compound, electronic element comprising same, and electronic device
CN115417806A (en) * 2022-09-30 2022-12-02 长春海谱润斯科技股份有限公司 Carbazole compound and organic electroluminescent device thereof
CN115417806B (en) * 2022-09-30 2024-02-20 长春海谱润斯科技股份有限公司 Carbazole compound and organic electroluminescent device thereof

Also Published As

Publication number Publication date
CN114394949B (en) 2023-11-10

Similar Documents

Publication Publication Date Title
EP3763707B1 (en) Amine derivative and an organic electroluminescent device thereof
CN111647009B (en) Boron-containing compound and electronic device thereof
CN112661714B (en) Heterocyclic compound and organic electroluminescent device containing same
CN110981899B (en) Polycyclic organoboron derivatives and electronic devices
CN110964002A (en) Arylamine derivative and organic light-emitting device thereof
CN113683630B (en) Nitrogen-containing heterocyclic derivative and organic electroluminescent device thereof
CN114394949B (en) Benzidine derivative and organic electroluminescent device thereof
CN114907217B (en) Triamine compound and organic electroluminescent device thereof
CN113845512B (en) Compound containing heterocycle and organic electroluminescent device thereof
KR20140027963A (en) Organic electroluminescent element
CN114621181B (en) Star-shaped tetramine derivative and organic electroluminescent device thereof
CN113666921B (en) Heterocyclic compound and organic electroluminescent device thereof
CN113845514B (en) Heterocyclic compound and organic electroluminescent device thereof
CN113698360B (en) Oxazole or thiazole compound and organic electroluminescent device thereof
CN115385802A (en) Organic electroluminescent device
CN114456161A (en) Imidazole derivative and organic electroluminescent device thereof
CN114899344B (en) Organic electroluminescent device
CN116874477A (en) Heteroatom-containing compound and organic electroluminescent device thereof
CN117143134A (en) Bicarbazole compound and organic electroluminescent device thereof
CN116655678A (en) Condensed ring compound for covering layer and organic electroluminescent device thereof
CN116730903A (en) Carbazole compound and organic electroluminescent device thereof
CN115811921A (en) Organic electroluminescent device
CN116003363A (en) Triarylamine compound and organic electroluminescent device thereof
CN117279469A (en) Organic electroluminescent device
CN114944459A (en) Organic electroluminescent device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant